Logo image of 1SAN.MI

SANOFI (1SAN.MI) Stock Fundamental Analysis

Europe - BIT:1SAN - FR0000120578 - Common Stock

80.23 EUR
+0.31 (+0.39%)
Last: 9/22/2025, 7:00:00 PM
Fundamental Rating

6

1SAN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 51 industry peers in the Pharmaceuticals industry. While 1SAN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1SAN has a correct valuation and a medium growth rate. Finally 1SAN also has an excellent dividend rating. This makes 1SAN very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

1SAN had positive earnings in the past year.
In the past year 1SAN had a positive cash flow from operations.
In the past 5 years 1SAN has always been profitable.
1SAN had a positive operating cash flow in each of the past 5 years.
1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCF1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

1SAN has a Return On Assets of 11.05%. This is in the better half of the industry: 1SAN outperforms 74.51% of its industry peers.
1SAN has a better Return On Equity (19.73%) than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.84%, 1SAN is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
1SAN had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 15.11%.
The last Return On Invested Capital (13.84%) for 1SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROIC 13.84%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1SAN.MI Yearly ROA, ROE, ROIC1SAN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 20.35%, 1SAN is doing good in the industry, outperforming 76.47% of the companies in the same industry.
In the last couple of years the Profit Margin of 1SAN has grown nicely.
The Operating Margin of 1SAN (23.59%) is comparable to the rest of the industry.
1SAN's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 71.70%, 1SAN perfoms like the industry average, outperforming 56.86% of the companies in the same industry.
1SAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
1SAN.MI Yearly Profit, Operating, Gross Margins1SAN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1SAN is creating value.
The number of shares outstanding for 1SAN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 1SAN has about the same amount of shares outstanding.
The debt/assets ratio for 1SAN has been reduced compared to a year ago.
1SAN.MI Yearly Shares Outstanding1SAN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1SAN.MI Yearly Total Debt VS Total Assets1SAN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1SAN has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as 1SAN would need 2.21 years to pay back of all of its debts.
The Debt to FCF ratio of 1SAN (2.21) is better than 82.35% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that 1SAN is not too dependend on debt financing.
1SAN has a better Debt to Equity ratio (0.21) than 70.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Altman-Z N/A
ROIC/WACC1.82
WACC7.6%
1SAN.MI Yearly LT Debt VS Equity VS FCF1SAN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

1SAN has a Current Ratio of 1.27. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
1SAN has a Current ratio (1.27) which is comparable to the rest of the industry.
A Quick Ratio of 0.94 indicates that 1SAN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, 1SAN is in line with its industry, outperforming 49.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.94
1SAN.MI Yearly Current Assets VS Current Liabilites1SAN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

The earnings per share for 1SAN have decreased by -2.20% in the last year.
Measured over the past 5 years, 1SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
1SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 6.45%.
Measured over the past years, 1SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%

3.2 Future

Based on estimates for the next years, 1SAN will show a small growth in Earnings Per Share. The EPS will grow by 6.41% on average per year.
1SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.04% yearly.
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.41%
Revenue Next Year-0.29%
Revenue Next 2Y3.32%
Revenue Next 3Y4.42%
Revenue Next 5Y4.04%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1SAN.MI Yearly Revenue VS Estimates1SAN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1SAN.MI Yearly EPS VS Estimates1SAN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.63, the valuation of 1SAN can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of 1SAN indicates a rather cheap valuation: 1SAN is cheaper than 80.39% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.54. 1SAN is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 9.25 indicates a reasonable valuation of 1SAN.
Based on the Price/Forward Earnings ratio, 1SAN is valued a bit cheaper than the industry average as 78.43% of the companies are valued more expensively.
1SAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.63
Fwd PE 9.25
1SAN.MI Price Earnings VS Forward Price Earnings1SAN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

1SAN's Enterprise Value to EBITDA ratio is in line with the industry average.
64.71% of the companies in the same industry are more expensive than 1SAN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.43
EV/EBITDA 10.34
1SAN.MI Per share data1SAN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1SAN does not grow enough to justify the current Price/Earnings ratio.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.58
PEG (5Y)2.09
EPS Next 2Y6.3%
EPS Next 3Y6.57%

8

5. Dividend

5.1 Amount

1SAN has a Yearly Dividend Yield of 4.93%, which is a nice return.
Compared to an average industry Dividend Yield of 3.03, 1SAN pays a better dividend. On top of this 1SAN pays more dividend than 84.31% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, 1SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.93%

5.2 History

The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1SAN pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
1SAN.MI Yearly Income VS Free CF VS Dividend1SAN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
1SAN.MI Dividend Payout.1SAN.MI Dividend Payout, showing the Payout Ratio.1SAN.MI Dividend Payout.PayoutRetained Earnings

SANOFI

BIT:1SAN (9/22/2025, 7:00:00 PM)

80.23

+0.31 (+0.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-24 2025-10-24/bmo
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap195.68B
Analysts80
Price Target109.75 (36.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.93%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-0.31%
PT rev (3m)-5.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.87%
EPS NY rev (1m)0.21%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE 10.63
Fwd PE 9.25
P/S 2.88
P/FCF 19.43
P/OCF 17.19
P/B 2.8
P/tB 21.05
EV/EBITDA 10.34
EPS(TTM)7.55
EY9.41%
EPS(NY)8.68
Fwd EY10.82%
FCF(TTM)4.13
FCFY5.15%
OCF(TTM)4.67
OCFY5.82%
SpS27.84
BVpS28.7
TBVpS3.81
PEG (NY)2.58
PEG (5Y)2.09
Profitability
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROCE 16.7%
ROIC 13.84%
ROICexc 16.48%
ROICexgc 66.95%
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
FCFM 14.83%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 58.05%
Profit Quality 72.91%
Current Ratio 1.27
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC7.6%
ROIC/WACC1.82
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.41%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year-0.29%
Revenue Next 2Y3.32%
Revenue Next 3Y4.42%
Revenue Next 5Y4.04%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y9.88%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%